Clinical Trial Update: The Fibrin Pad Cardiovascular Study [Phase 2]

View source ↗

Summary

Ethicon's Phase 2 Fibrin Pad cardiovascular study has completed enrollment and posted results on March 7, 2018. The trial evaluated the fibrin pad device for ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Fibrin Pad

Snippet

Sponsor: Ethicon, Inc. | Conditions: Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-03-07